NEW YORK (GenomeWeb) – Ubiquitome is commercializing a 16-well real-time PCR instrument aimed at personalizing the method and making it more accessible to researchers. The Liberty16 instrument is designed for use in the field but is also being marketed as an affordable way to reduce backlog in research labs.

Ubiquitome has promised to make genomics ubiquitous by providing portable and low-cost qPCR solutions. "We feel like we've made a big and bold step forward with the Liberty16 around that promise," the firm's founder and CEO, Paul Pickering, said in an interview.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The data generated by 100,000 Genomes Project is being housed on military servers due to attacks by hackers, Naked Security reports.

A new poll finds most US adults are not familiar with personalized medicine, according to HealthDay.

Vox reports that the United Nations' Convention on Biological Diversity decided against a gene drive moratorium.

In Science this week: sequencing of neuroblastomas uncovers alterations linked to prognosis, and more.

Sponsored by

This webinar will discuss the use of shotgun metagenomics to identify children at risk of hospital-acquired infection.